查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1806534

神經刺激設備市場按產品類型、材料類型、電源、技術、年齡層、應用、最終用戶和分銷管道分類 - 全球預測 2025-2030

Neurostimulation Device Market by Product Type, Material Type, Power Source, Technology, Age Group, Application, End User, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計神經刺激設備市場在 2024 年的價值將達到 66.2 億美元，在 2025 年成長至 73.9 億美元，複合年成長率為 11.89%，到 2030 年將達到 130 億美元。

主要市場統計數據
基準年2024年 66.2億美元
預計2025年 73.9億美元
預測年份 2030 130億美元
複合年成長率（%） 11.89%

在這個神經病變和感覺障礙困擾全球數百萬人的時代，神經刺激設備應運而生，成為革命性的解決方案。這些技術將定向電脈衝傳送至特定的神經通路，從而恢復功能或緩解慢性症狀。從恢復聽力的人工電子耳到改變帕金森氏症患者生活的深層腦部刺激器，神經刺激技術始終處於醫學創新的前沿。

本執行摘要提煉了塑造神經刺激設備最重要的發展。它簡潔而全面地概述了該行業的演變，重點介紹了推動應用的因素、製造商面臨的挑戰以及他們應該抓住的機會。包括設備開發商、醫療保健提供者、投資者和監管機構在內的相關人員可以發現新興趨勢、策略挑戰和競爭格局。

本書整合了產業領先觀點、監管文件和技術藍圖的洞見，為決策者提供應對複雜情況所需的知識。無論您對研發、打入市場策略或夥伴關係關係感興趣，本書都能幫助您深入了解那些將定義神經刺激未來發展的主題。

了解神經刺激領域的變化：新興技術進步、監管趨勢和臨床實踐

過去十年，隨著材料科學、設備小型化和數位整合技術的進步，神經刺激領域發生了顯著變化。如今，植入式刺激器整合了閉合迴路回饋系統，可即時調整治療方法，從而提高療效並減少副作用。同時，電池技術的創新延長了設備的使用壽命，無線連接選項則允許透過雲端對應平臺進行遠端監控和個人化調整。

2025年美國關稅政策對神經刺激設備供應鏈成本與競爭的累積影響分析

美國已於2025年實施新關稅，對進口的金屬生物材料、電子元件以及用於神經刺激設備的某些聚合物材料徵收額外關稅。製造商面臨採購成本上升的局面，這種局面會波及整個供應鏈，迫使他們重新評估籌資策略以及與海外供應商的合約條款。因此，生產預算需要重新分配，以彌補增加的關稅成本，這給產品價格和利潤率帶來了壓力。

從神經刺激市場的產品材料、功率、使用年限、應用和最終用戶維度獲取關鍵細分洞察

深入研究細分領域，可以發現其在多個維度上呈現出微妙的成長軌跡。在評估產品類型時，人工電子耳在適應症不斷擴展的推動下保持著強勁的研發管線，而脊髓刺激設備和迷走神經刺激設備在慢性疼痛和癲癇治療中的應用正在加速。在材料領域，金屬生物材料因其經過驗證的生物相容性而繼續佔據主導地位，而聚合物替代品則因其靈活性和成本效益而日益普及。

揭示推動亞太地區神經刺激治療領域成長機會和採用模式的關鍵區域動態

區域評估揭示了不同的成熟度曲線和採用模式。在美洲，美國憑藉高報銷率和強勁的臨床試驗活動處於領先地位，而加拿大在其公共醫療框架內也表現出穩步的採用。拉丁美洲的成長情況參差不齊，受制於較小經濟體的預算限制，以及都市區對先進醫療基礎設施的投資。

了解塑造神經刺激技術和臨床解決方案未來的關鍵參與者的策略性舉措和關鍵產品組合發展

競爭格局正由全球知名領導者和敏捷創新者塑造。大型醫療設備公司透過策略性收購專業新興企業以及與科技公司合作，持續拓展其神經刺激產品組合。近期，一家電生理學先驅與數位健康公司合作，打造了一個封閉回路型刺激與遠端分析結合的平台，旨在提升患者療效並支持臨床決策。

我們制定可行的策略建議，幫助產業領導者加速創新採用、最佳化營運並加強其市場定位。

產業領導者應優先投資新一代材料，以減少器械外形尺寸、提升病患舒適度，同時維持電氣性能。與學術機構和合約研究組織建立研發合作夥伴關係，將加速概念驗證研究，並釋放新的適應症。企業也應透過簽訂雙源協議和探索區域製造中心來實現供應來源多元化，以應對地緣政治和關稅波動。

為神經刺激療法開發全面的調查方法，包括資料收集方法和分析過程

本分析所採用的調查方法架構結合了定性和定量方法，以確保嚴謹性和可靠性。主要訪談對象包括神經科、生物醫學工程師、供應鏈經理和付款人代表，旨在收集有關未滿足臨床需求、生產挑戰和報銷障礙的第一手資料。這些資料與來自監管備案文件、同行評審期刊和會議論文集的二手資料進行了整合。

綜合策略見解並得出總體結論，以闡明神經刺激市場的現狀和預測的未來發展軌跡

透過綜合技術發展軌跡、監管趨勢、市場細分和區域應用模式，本分析提供了對當前神經刺激生態系統的全面理解。關鍵要點強調了閉合迴路系統和先進生物材料在推動下一代設備性能、平衡新關稅措施和供應鏈重組帶來的營運需求方面的重要性。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章市場動態

  • 擴大監管核准加速創新神經刺激設備進入市場
  • 科技公司和醫療保健提供者合作改進神經刺激技術
  • 穿戴式神經刺激設備在慢性疼痛管理的應用日益增多
  • 神經刺激療法對於憂鬱症和焦慮症等精神疾病變得越來越重要。
  • 用於家庭治療和長期使用的攜帶式神經刺激設備的開發
  • 非侵入性神經刺激技術的進步提高了患者的舒適度和治療效果
  • 將人工智慧和機器學習融入神經刺激設備程式設計和個人化
  • 加強神經調節在神經退化性疾病治療和復健的研究
  • 無線神經刺激設備的出現提高了患者的活動能力和依從性
  • 專注於具有成本效益的神經刺激設備，以提高其在新興市場的可及性

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

第 8 章神經刺激設備市場（依產品類型）

  • 人工電子耳
  • 深層腦部刺激器（DBS）
  • 薦骨神經刺激器（SNS）
  • 脊髓刺激設備（SCS）
  • 迷走神經刺激設備（VNS）

第9章神經刺激設備市場（依材料類型）

  • 金屬生醫材料
  • 聚合物生醫材料

第 10 章神經刺激設備市場（按電源）

  • 非充電式神經刺激設備
  • 可充電神經刺激設備

第 11 章神經刺激設備市場（按技術）

  • 植入式神經刺激設備
  • 非植入式裝置

第12章神經刺激設備市場（依年齡層）

  • 成人
  • 老年人
  • 孩子們

第13章神經刺激設備市場（按應用）

  • 胃腸道疾病
  • 聽力損失
  • 神經系統疾病
    • 肌張力不全症
    • 癲癇
    • 自發性震顫
    • 帕金森氏症
  • 疼痛管理
    • 癌症痛
    • 慢性疼痛
  • 睡眠呼吸中止症
  • 尿失禁和大便失禁
    • 腸道疾病
    • 膀胱過動症

第 14 章神經刺激設備市場（按最終用戶）

  • 門診手術中心（ASC）
  • 家庭醫療保健
  • 醫院
  • 專科診所

第 15 章神經刺激設備市場（依通路）

  • 離線
  • 線上

第 16 章：美洲神經刺激設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

17. 歐洲、中東和非洲神經刺激設備市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

第 18 章：亞太神經刺激設備市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第19章 競爭態勢

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Abbott Laboratories
    • Bayer AG
    • Beijing PINS Medical Co.
    • Bioventus Inc.
    • Boston Scientific Corporation
    • Cefaly Technology
    • Curonix LLC.
    • electroCore Inc
    • InCube Labs.
    • Integra LifeSciences Holdings Corporation
    • LivaNova PLC
    • Medtronic PLC
    • MicroTransponder, Inc.
    • Motif Neurotech, Inc.
    • Neurosigma, Inc.
    • Nevro Corporation
    • SceneRay Co., Ltd
    • Soterix Medical, Inc.
    • Stimwave LLC
    • Synapse Biomedical Inc.

第20章 研究人工智慧

第21章 研究統計

第22章 研究聯絡人

第23章 研究報導

第24章 附錄

Product Code: MRR-036C5CF3B4E1

The Neurostimulation Device Market was valued at USD 6.62 billion in 2024 and is projected to grow to USD 7.39 billion in 2025, with a CAGR of 11.89%, reaching USD 13.00 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 6.62 billion
Estimated Year [2025] USD 7.39 billion
Forecast Year [2030] USD 13.00 billion
CAGR (%) 11.89%

In an era where neurological disorders and sensory impairments affect millions worldwide, neurostimulation devices have emerged as a groundbreaking solution. These technologies deliver targeted electrical impulses to specific neural pathways, restoring function or alleviating chronic conditions. From cochlear implants that grant the gift of hearing to deep brain stimulators that transform the lives of patients with Parkinson's disease, neurostimulation stands at the cutting edge of medical innovation.

This executive summary distills the most critical developments shaping the landscape of neurostimulation devices. It provides a concise yet comprehensive overview of the industry's evolution, highlighting the forces driving adoption, the challenges confronting manufacturers, and the opportunities waiting to be seized. Stakeholders, including device developers, healthcare providers, investors, and regulatory authorities, will gain clarity on emerging trends, strategic imperatives, and the competitive landscape.

By synthesizing insights from leading industry voices, regulatory documents, and technological roadmaps, this document equips decision-makers with the knowledge required to navigate complexity. Whether your interest lies in research and development, market entry strategies, or partnership opportunities, this introduction sets the stage for a deeper exploration of the themes that will define the future of neurostimulation.

Understanding Transformational Shifts Reshaping the Neurostimulation Landscape: Emerging Technological Advances Regulatory Trends and Clinical Practices

Over the past decade, the neurostimulation landscape has been revolutionized by advances in materials science, device miniaturization, and digital integration. Implantable stimulators now incorporate closed-loop feedback systems that adapt therapy in real time, enhancing efficacy and reducing side effects. Concurrently, battery innovations have extended device longevity, while wireless connectivity options enable remote monitoring and personalized adjustments through cloud-enabled platforms.

Regulatory frameworks have evolved in tandem. Expedited review pathways and breakthrough device designations in the United States have accelerated approval times for novel therapies, while the European Union's Medical Device Regulation has raised the bar for clinical evidence and post-market surveillance. This regulatory convergence fosters greater global harmonization but also intensifies the demand for rigorous clinical validation and robust risk management.

Clinical practice guidelines are shifting as well. Physicians are increasingly adopting neuromodulation for off-label applications, driven by compelling real-world evidence. Reimbursement models have adapted to recognize the long-term cost savings associated with reduced medication use and hospital readmissions. Altogether, these transformational shifts are redefining the competitive imperatives for all stakeholders and creating new pathways for patient-centric innovation.

Analyzing the Cumulative Effects of 2025 United States Tariff Policies on Neurostimulation Device Supply Chains Costs and Competitive Positioning

The introduction of new tariff measures by the United States in 2025 has imposed additional duties on imported metallic biomaterials, electronic components, and certain polymeric supplies used in neurostimulation devices. Manufacturers face elevated procurement costs that cascade through the supply chain, prompting a reassessment of sourcing strategies and contract terms with overseas suppliers. As a result, production budgets have been reallocated to cover incremental tariff expenses, adding pressure on product pricing and profit margins.

In response, many firms have turned to nearshoring initiatives, relocating critical manufacturing steps to repatriated facilities within North America. This shift not only mitigates tariff burdens but also reduces logistical risks and lead times. To sustain cost competitiveness, device companies are engaging in proactive negotiations with strategic vendors and exploring alternative material formulations to hedge against duty fluctuations.

Despite these challenges, the industry has demonstrated resilience. Collaborative partnerships between raw material providers and device manufacturers have yielded joint cost-containment programs. Operational teams have optimized inventory management and streamlined customs processes. While the immediate impact manifested as temporary price adjustments, these collective efforts have laid the groundwork for a more agile and tariff-resilient supply chain moving forward.

Deriving Critical Segmentation Insights from Product Material Power Age Application and End User Dimensions in Neurostimulation Markets

A deep dive into the segmentation landscape reveals nuanced growth trajectories across multiple dimensions. When evaluating product type, cochlear implants maintain a robust pipeline driven by expanding indications, while spinal cord stimulators and vagus nerve stimulators show accelerated uptake in chronic pain and epilepsy management. Within the material realm, metallic biomaterials continue to dominate due to their proven biocompatibility, yet polymeric alternatives are gaining traction for their flexibility and cost efficiency.

Power source distinctions also shape market dynamics. Rechargeable neurostimulators are favored for their longevity and reduced need for surgical replacement, whereas non-rechargeable devices maintain stable demand in applications with limited power requirements. Implantable systems command a premium position, leveraging invasive techniques for targeted therapy, but non-implantable technologies are expanding access through wearable stimulators for conditions like sleep apnea.

Demographic factors further refine opportunity zones. Pediatric patients represent a specialized segment where device miniaturization and safety protocols are paramount, while geriatric populations drive demand in chronic pain and movement disorder treatments. In adult cohorts, applications span gastrointestinal disorders to urinary and fecal incontinence. Neurological disorder sub-segments such as dystonia, epilepsy, essential tremor, and Parkinson's disease present distinct clinical needs, as do pain management subdivisions focusing on cancer and chronic pain. End-user environments range from ambulatory surgery centers to home healthcare settings, with specialty clinics serving as centers of excellence. Offline channels remain the predominant route to market, though online platforms are emerging for post-market device support and remote programming services.

Unveiling Key Regional Dynamics Driving Growth Opportunities and Adoption Patterns across Americas EMEA and Asia Pacific Neurostimulation Sectors

Regional evaluation uncovers differing maturity curves and adoption patterns. In the Americas, the United States leads with high reimbursement rates and strong clinical trial activity, while Canada shows steady uptake under public healthcare frameworks. Latin America exhibits variable growth, propelled by urban centers that invest in advanced medical infrastructure, albeit tempered by budget constraints in smaller economies.

Within Europe, Middle East & Africa, Western European markets benefit from harmonized regulatory pathways and established neuromodulation programs, whereas Eastern European regions are gradually integrating advanced devices into public systems. The Middle East is characterized by government-funded healthcare initiatives that prioritize flagship hospitals, and Africa's market remains nascent, driven by select private facilities in urban hubs.

Asia-Pacific presents a dual narrative: Japan's well-funded research ecosystem and aging population fuel innovation and demand, while China's domestic players intensify competition through localized manufacturing and price-competitive offerings. In India and Southeast Asia, government investments in healthcare infrastructure and rising disposable incomes are unlocking new patient pools. Across these regions, digital health integration and telemedicine frameworks are rapidly evolving, facilitating remote patient monitoring and expanding the reach of neuromodulation therapies.

Illuminating Leading Strategic Moves and Portfolio Developments from Key Players Shaping the Future of Neurostimulation Technology and Clinical Solutions

The competitive landscape is shaped by established global leaders and agile innovators. Major medical device corporations continue to expand their neuromodulation portfolios through strategic acquisitions of specialist startups and partnerships with technology firms. Recent collaborations between electrophysiology pioneers and digital health companies have produced platforms that combine closed-loop stimulation with remote analytics, enhancing patient outcomes and clinical decision support.

Several players have advanced high-frequency stimulation modalities, targeting specific neuronal pathways with unprecedented precision. Others are developing next-generation electrode arrays with bioactive coatings to minimize fibrotic responses. Concurrently, emerging companies are introducing cost-effective non-implantable stimulators aimed at home-based applications, democratizing access for broader patient populations.

Leadership is increasingly defined by the ability to integrate multidisciplinary expertise-from neuroscience and materials engineering to software development and data analytics. Firms that demonstrate agility in navigating regulatory submissions, securing reimbursement coding, and scaling manufacturing will be best positioned to capitalize on the expanding neurostimulation market. Portfolio breadth, coupled with clinical evidence generation, remains the cornerstone of sustainable competitive advantage.

Formulating Actionable Strategic Recommendations to Help Industry Leaders Accelerate Innovation Adoption Optimize Operations and Strengthen Market Positioning

Industry leaders should prioritize investment in next-generation materials that reduce device profile and enhance patient comfort while maintaining electrical performance. Collaborative R&D alliances with academic institutions and contract research organizations will accelerate proof-of-concept studies and unlock novel indications. Companies must also diversify supply reservoirs by establishing dual-source agreements and exploring regional manufacturing hubs to buffer against geopolitical and tariff-related disruptions.

Engaging proactively with regulatory bodies can streamline approval processes; early dialogue regarding clinical trial design and risk-benefit analyses will mitigate uncertainties. Payers and providers should be engaged through value-based contracting models that align reimbursement with long-term patient outcomes. Training programs for surgeons and allied health professionals will support adoption of complex implantable systems, while digital literacy initiatives will increase patient acceptance of remote monitoring tools.

Finally, embracing data-driven service offerings-such as predictive maintenance of implantable devices and AI-powered therapy optimization-will create recurring revenue streams and strengthen customer loyalty. By executing these actionable recommendations, organizations can chart a course toward sustained innovation and commercial success in the evolving neurostimulation arena.

Articulating a Comprehensive Research Framework Including Methodological Approaches Data Collection Techniques and Analytical Processes for Neurostimulation

The research framework underpinning this analysis combines qualitative and quantitative methodologies to ensure rigor and reliability. Primary interviews were conducted with neurologists, biomedical engineers, supply chain directors, and payer representatives to gather firsthand perspectives on unmet clinical needs, manufacturing challenges, and reimbursement hurdles. These insights were triangulated with secondary data sourced from regulatory filings, peer-reviewed journals, and conference proceedings.

Material supply chain mapping employed trade data and customs records to identify key suppliers of metallic and polymeric biomaterials, while device shipment analytics highlighted regional distribution trends. Technology assessment drew upon patent landscape evaluations and product registries to track innovation trajectories in implantable and non-implantable devices. Clinical trial databases were mined to quantify study volumes across applications ranging from gastrointestinal disorders to movement disorders.

Analytical processes included scenario modeling to assess the impact of tariff adjustments and statistical clustering to uncover latent segmentation patterns. Data validation protocols were implemented through cross-referencing multiple independent sources, and an internal review board oversaw quality control measures. This comprehensive methodology ensures that the findings presented herein rest upon a robust evidentiary foundation, offering decision-makers a high degree of confidence in strategic planning and investment decisions.

Drawing Holistic Conclusions by Synthesizing Strategic Findings to Illuminate the Neurostimulation Market's Current State and Anticipated Future Trajectory

By synthesizing technological trajectories, regulatory developments, market segmentation, and regional adoption patterns, this analysis offers a holistic understanding of the current neurostimulation ecosystem. Key takeaways emphasize the importance of closed-loop systems and advanced biomaterials in driving next-generation device performance, balanced against the operational imperatives imposed by new tariff measures and supply chain realignments.

Segmentation insights highlight that cochlear implants and spinal cord stimulators will continue to anchor the market, even as emerging applications in gastrointestinal and urinary disorders unlock new growth corridors. Regional dynamics underscore the United States and Western Europe as early adopters, while Asia-Pacific and select Latin American markets present rapid expansion potential underpinned by healthcare investments and demographic shifts.

Competitive positioning will hinge on the ability to deliver clinically validated, patient-centric solutions at scale. Firms that effectively integrate cross-disciplinary expertise, leverage digital health platforms for remote care, and forge resilient supply networks will lead the charge. This conclusion sets the stage for executives to refine their strategic roadmaps and capitalize on the untapped opportunities across the multifaceted neurostimulation landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Expansion of regulatory approvals speeding up market entry for innovative neurostimulation devices
  • 5.2. Collaborations between tech companies and healthcare providers to improve neurostimulation technologies
  • 5.3. Rising adoption of wearable neurostimulation devices for chronic pain management
  • 5.4. Growing emphasis on neurostimulation solutions for mental health disorders like depression and anxiety
  • 5.5. Development of portable neurostimulation devices for home-based therapy and long-term use
  • 5.6. Advancements in non-invasive neurostimulation techniques enhancing patient comfort and outcomes
  • 5.7. Integration of AI and machine learning in neurostimulation device programming and personalization
  • 5.8. Increasing research on neuromodulation for neurodegenerative disease treatment and rehabilitation
  • 5.9. Emergence of wireless neurostimulation devices improving patient mobility and compliance
  • 5.10. Focus on cost-effective neurostimulation devices to enhance accessibility in emerging markets

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Neurostimulation Device Market, by Product Type

  • 8.1. Introduction
  • 8.2. Cochlear Implants
  • 8.3. Deep Brain Stimulators (DBS)
  • 8.4. Sacral Nerve Stimulators (SNS)
  • 8.5. Spinal Cord Stimulators (SCS)
  • 8.6. Vagus Nerve Stimulators (VNS)

9. Neurostimulation Device Market, by Material Type

  • 9.1. Introduction
  • 9.2. Metallic Biomaterials
  • 9.3. Polymeric Biomaterials

10. Neurostimulation Device Market, by Power Source

  • 10.1. Introduction
  • 10.2. Non-Rechargeable Neurostimulators
  • 10.3. Rechargeable Neurostimulators

11. Neurostimulation Device Market, by Technology

  • 11.1. Introduction
  • 11.2. Implantable Neurostimulation Devices
  • 11.3. Non-Implantable Devices

12. Neurostimulation Device Market, by Age Group

  • 12.1. Introduction
  • 12.2. Adult
  • 12.3. Geriatric
  • 12.4. Pediatric

13. Neurostimulation Device Market, by Application

  • 13.1. Introduction
  • 13.2. Gastrointestinal Disorders
  • 13.3. Hearing Loss
  • 13.4. Neurological Disorders
    • 13.4.1. Dystonia
    • 13.4.2. Epilepsy
    • 13.4.3. Essential Tremor
    • 13.4.4. Parkinson's Disease
  • 13.5. Pain Management
    • 13.5.1. Cancer Pain
    • 13.5.2. Chronic Pain
  • 13.6. Sleep Apnea
  • 13.7. Urinary & Fecal Incontinence
    • 13.7.1. Bowel Disorders
    • 13.7.2. Overactive Bladder

14. Neurostimulation Device Market, by End User

  • 14.1. Introduction
  • 14.2. Ambulatory Surgery Centers (ASCs)
  • 14.3. Home Healthcare
  • 14.4. Hospitals
  • 14.5. Specialty Clinics

15. Neurostimulation Device Market, by Distribution Channel

  • 15.1. Introduction
  • 15.2. Offline
  • 15.3. Online

16. Americas Neurostimulation Device Market

  • 16.1. Introduction
  • 16.2. United States
  • 16.3. Canada
  • 16.4. Mexico
  • 16.5. Brazil
  • 16.6. Argentina

17. Europe, Middle East & Africa Neurostimulation Device Market

  • 17.1. Introduction
  • 17.2. United Kingdom
  • 17.3. Germany
  • 17.4. France
  • 17.5. Russia
  • 17.6. Italy
  • 17.7. Spain
  • 17.8. United Arab Emirates
  • 17.9. Saudi Arabia
  • 17.10. South Africa
  • 17.11. Denmark
  • 17.12. Netherlands
  • 17.13. Qatar
  • 17.14. Finland
  • 17.15. Sweden
  • 17.16. Nigeria
  • 17.17. Egypt
  • 17.18. Turkey
  • 17.19. Israel
  • 17.20. Norway
  • 17.21. Poland
  • 17.22. Switzerland

18. Asia-Pacific Neurostimulation Device Market

  • 18.1. Introduction
  • 18.2. China
  • 18.3. India
  • 18.4. Japan
  • 18.5. Australia
  • 18.6. South Korea
  • 18.7. Indonesia
  • 18.8. Thailand
  • 18.9. Philippines
  • 18.10. Malaysia
  • 18.11. Singapore
  • 18.12. Vietnam
  • 18.13. Taiwan

19. Competitive Landscape

  • 19.1. Market Share Analysis, 2024
  • 19.2. FPNV Positioning Matrix, 2024
  • 19.3. Competitive Analysis
    • 19.3.1. Abbott Laboratories
    • 19.3.2. Bayer AG
    • 19.3.3. Beijing PINS Medical Co.
    • 19.3.4. Bioventus Inc.
    • 19.3.5. Boston Scientific Corporation
    • 19.3.6. Cefaly Technology
    • 19.3.7. Curonix LLC.
    • 19.3.8. electroCore Inc
    • 19.3.9. InCube Labs.
    • 19.3.10. Integra LifeSciences Holdings Corporation
    • 19.3.11. LivaNova PLC
    • 19.3.12. Medtronic PLC
    • 19.3.13. MicroTransponder, Inc.
    • 19.3.14. Motif Neurotech, Inc.
    • 19.3.15. Neurosigma, Inc.
    • 19.3.16. Nevro Corporation
    • 19.3.17. SceneRay Co., Ltd
    • 19.3.18. Soterix Medical, Inc.
    • 19.3.19. Stimwave LLC
    • 19.3.20. Synapse Biomedical Inc.

20. ResearchAI

21. ResearchStatistics

22. ResearchContacts

23. ResearchArticles

24. Appendix

LIST OF FIGURES

  • FIGURE 1. NEUROSTIMULATION DEVICE MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 16. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 18. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
  • FIGURE 20. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 24. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 27. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 28. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 29. NEUROSTIMULATION DEVICE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. NEUROSTIMULATION DEVICE MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 31. NEUROSTIMULATION DEVICE MARKET: RESEARCHAI
  • FIGURE 32. NEUROSTIMULATION DEVICE MARKET: RESEARCHSTATISTICS
  • FIGURE 33. NEUROSTIMULATION DEVICE MARKET: RESEARCHCONTACTS
  • FIGURE 34. NEUROSTIMULATION DEVICE MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. NEUROSTIMULATION DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COCHLEAR IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COCHLEAR IMPLANTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DEEP BRAIN STIMULATORS (DBS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DEEP BRAIN STIMULATORS (DBS), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SACRAL NERVE STIMULATORS (SNS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SACRAL NERVE STIMULATORS (SNS), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SPINAL CORD STIMULATORS (SCS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SPINAL CORD STIMULATORS (SCS), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY VAGUS NERVE STIMULATORS (VNS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY VAGUS NERVE STIMULATORS (VNS), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY METALLIC BIOMATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY METALLIC BIOMATERIALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POLYMERIC BIOMATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POLYMERIC BIOMATERIALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NON-RECHARGEABLE NEUROSTIMULATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NON-RECHARGEABLE NEUROSTIMULATORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY RECHARGEABLE NEUROSTIMULATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY RECHARGEABLE NEUROSTIMULATORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY IMPLANTABLE NEUROSTIMULATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY IMPLANTABLE NEUROSTIMULATION DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NON-IMPLANTABLE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NON-IMPLANTABLE DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HEARING LOSS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HEARING LOSS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DYSTONIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DYSTONIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY EPILEPSY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ESSENTIAL TREMOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ESSENTIAL TREMOR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY CANCER PAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY CANCER PAIN, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SLEEP APNEA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SLEEP APNEA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY BOWEL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY BOWEL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY OVERACTIVE BLADDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY OVERACTIVE BLADDER, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS (ASCS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS (ASCS), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 99. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 101. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 103. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
  • TABLE 105. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 107. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 109. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 111. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 113. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 115. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2025-2030 (USD MILLION)
  • TABLE 117. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 119. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 121. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 123. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 124. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 125. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 126. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 127. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
  • TABLE 128. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
  • TABLE 129. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 130. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 131. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 133. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 134. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 135. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 136. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 137. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 138. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 139. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2024 (USD MILLION)
  • TABLE 140. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2025-2030 (USD MILLION)
  • TABLE 141. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 142. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 143. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 144. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 145. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 146. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 147. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 149. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 151. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
  • TABLE 152. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
  • TABLE 153. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 154. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 155. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 157. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 158. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 159. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 160. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 161. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 162. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 163. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2024 (USD MILLION)
  • TABLE 164. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2025-2030 (USD MILLION)
  • TABLE 165. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 167. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 168. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 169. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 171. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 173. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
  • TABLE 174. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
  • TABLE 175. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 176. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 177. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 179. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 181. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 182. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 183. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 184. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 185. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2024 (USD MILLION)
  • TABLE 186. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2025-2030 (USD MILLION)
  • TABLE 187. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 189. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 190. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 191. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 193. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 195. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
  • TABLE 196. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
  • TABLE 197. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 198. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 199. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 201. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 203. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 204. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 205. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 206. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 207. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2024 (USD MILLION)
  • TABLE 208. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2025-2030 (USD MILLION)
  • TABLE 209. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 211. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 212. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 213. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 215. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 217. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
  • TABLE 218. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
  • TABLE 219. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 220. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 221. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 223. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 225. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 226. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 227. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 228. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 229. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2024 (USD MILLION)
  • TABLE 230. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2025-2030 (USD MILLION)
  • TABLE 231. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 233. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 234. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2025-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 259. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 261. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 263. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
  • TABLE 264. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
  • TABLE 265. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 266. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 267. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 269. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 271. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 272. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 274. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2024 (USD MILLION)
  • TABLE 276. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2025-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 280. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 281. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 283. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 285. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
  • TABLE 286. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
  • TABLE 287. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 288. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 289. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 290. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 291. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 293. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 294. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 295. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 296. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 297. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2024 (USD MILLION)
  • TABLE 298. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2025-2030 (USD MILLION)
  • TABLE 299. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 301. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 302. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 303. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 305. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 307. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
  • TABLE 308. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
  • TABLE 309. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 310. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 311. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 312. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 313. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 314. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 315. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 316. FRANCE NEUROSTIMULATION D